MedDataX Logo

Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique

NCT ID: NCT02935049

Last Updated: 2017-10-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Study Completion Date

2018-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For tough colic resection, evaluation of our practice for these lesions unresectable in monoblock and evaluation of the contribution of the hybrid technique EMR (mucosectomy dissection) /ESD (submucosal dissection)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Adenoma Intramucinous Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic resection

Endoscopic resection with technique EMR piecemeal or hybrid technique EMR/ESD

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years,
* Patient with colorectal adenoma or intramucinous adenocarcinoma

Exclusion Criteria

* Contraindication surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Paoli-Calmettes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

RATONE Jean Philippe, MD

Role: PRINCIPAL_INVESTIGATOR

Institut Paoli-Calmettes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GENRE

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

GENRE Dominique, MD

Role: CONTACT

Phone: +33 (4) 91 22 37 78

Email: [email protected]

COURNIER Sandra, Project Manager

Role: CONTACT

Phone: +33 (4) 91 22 37 78

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

GENRE Dominique, MD

Role: primary

COURNIER Sandra, Project Manager

Role: backup

Related Links

Access external resources that provide additional context or updates about the study.

http://www.institutpaolicalmettes.fr

Institut Paoli-Calmettes

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HYBRID ESD-IPC 2016-015

Identifier Type: -

Identifier Source: org_study_id